We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$124B
| $192M | 0.85% |
957,945
-184,600
| -16% | -$37.5M |
|
27
Booking.com
BKNG
$160B
| $187M | 0.83% |
1,761,925
+578,475
| +49% | +$56.3M |
|
28
PepsiCo
PEP
$189B
| $172M | 0.76% |
943,829
-62,484
| -6% | -$10.9M |
|
29
PayPal
PYPL
$50.5B
| $171M | 0.76% |
2,251,026
+824,063
| +58% | +$63.5M |
|
|
30
Netflix
NFLX
$311B
| $165M | 0.73% |
4,774,270
+4,065,400
| +574% | +$135M |
|
31
Kroger
KR
$34.5B
| $154M | 0.68% |
3,120,839
+125,300
| +4% | +$5.73M |
|
32
Bristol-Myers Squibb
BMY
$130B
| $154M | 0.68% |
2,218,242
-168,242
| -7% | -$11.9M |
|
33
Paychex
PAYX
$43.1B
| $153M | 0.68% |
1,335,221
+42,818
| +3% | +$4.87M |
|
34
ServiceNow
NOW
$132B
| $150M | 0.67% |
1,613,375
-121,140
| -7% | -$10.6M |
|
35
Johnson & Johnson
JNJ
$626B
| $150M | 0.67% |
966,740
-438,382
| -31% | -$70.8M |
|
36
Berkshire Hathaway Class B
BRK.B
$1.11T
| $146M | 0.65% |
473,519
-239,980
| -34% | -$74M |
|
37
Vertex Pharmaceuticals
VRTX
$134B
| $144M | 0.64% |
457,155
+10,144
| +2% | +$3.04M |
|
38
Philip Morris
PM
$290B
| $143M | 0.64% |
1,474,296
+165,757
| +13% | +$16.5M |
|
39
Chevron
CVX
$386B
| $137M | 0.61% |
841,663
-253,897
| -23% | -$42.6M |
|
40
Brown-Forman Class B
BF.B
$12.9B
| $127M | 0.56% |
1,974,196
-291,884
| -13% | -$19M |
|
41
MSCI
MSCI
$40.8B
| $127M | 0.56% |
226,476
+223,789
| +8,329% | +$118M |
|
42
Eli Lilly
LLY
$1.08T
| $123M | 0.55% |
358,378
+265,916
| +288% | +$89.7M |
|
43
Adobe
ADBE
$105B
| $118M | 0.52% |
306,843
+32,472
| +12% | +$11.5M |
|
44
Motorola Solutions
MSI
$77.3B
| $115M | 0.51% |
401,582
-2,988
| -0.7% | -$789K |
|
45
Hershey
HSY
$36.6B
| $114M | 0.51% |
449,014
+155,221
| +53% | +$36.5M |
|
46
Caterpillar
CAT
$388B
| $112M | 0.5% |
489,695
+157,945
| +48% | +$38.2M |
|
47
Procter & Gamble
PG
$338B
| $109M | 0.48% |
731,236
+120,989
| +20% | +$17.3M |
|
48
Paycom
PAYC
$9.57B
| $106M | 0.47% |
349,894
-10,592
| -3% | -$3.19M |
|
|
49
Home Depot
HD
$353B
| $102M | 0.45% |
345,766
-617,181
| -64% | -$189M |
|
50
PACCAR
PCAR
$69.8B
| $102M | 0.45% |
1,392,866
+797,957
| +134% | +$57.1M |
|
Similar funds
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.